Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of 16 weeks treatment with vildagliptin to
pioglitazone as add-on the therapy to metformin in patients with type 2 diabetes inadequately
controlled with metformin monotherapy.